Article 06 Jan 2026 CMS Proposes MFN Drug Pricing Strategy For Mandatory GLOBE And GUARD Models United States Healthcare
Article 23 Dec 2025 The EU Pharma Package Is A Done Deal: A Holiday Gift, Or Not? Worldwide Healthcare
Article 17 Dec 2025 Most Favored Nation Drug Pricing And Manufacturer Agreements United States Healthcare
Article 17 Dec 2025 The Current Legal Landscape Of The 340B Drug Pricing Program United States Healthcare
Article 17 Dec 2025 FDA's Support For Onshoring Drug Manufacturing And Increasing Oversight Of Foreign Facilities United States Healthcare
Article 09 Dec 2025 FDA's Biosimilar Playbook: Merging Biosimilarity With Interchangeability United States Healthcare
Article 06 Nov 2025 FDA Proposes To Remove Comparative Efficacy Studies To Accelerate Biosimilar Development United States Healthcare